Home
Activity Overview
Related Articles
Psychopharmacology Update
This in-person conference is a wonderful opportunity to share in valuable face-to-face engagement while also learning about the latest advancements in the field. Once again,…
Ascletis Receives FDA Clearance to Advance ASC50, a Novel Oral IL-17 Inhibitor, Into Phase 1 Psoriasis Trial
Ascletis Pharma’s investigational new drug application for ASC50 gains FDA clearanc for a phase 1 trial for mild to moderate psoriasis.
Home
Thursday, 12 June 2025 08:00 – 09:30 CEST Allianz MiCo – Milano Convention Centre | 20149 Milan, Italy Room: Brown Hall 3 CPD Hybrid Multiple…
New Study Evaluates Accuracy of Hand Eczema Self-Assessments
Explore the evolving landscape of self-reported hand eczema severity assessments, highlighting their potential and challenges in clinical research and digital health.
Psychiatry Update 2024
We are pleased to invite you to the 2024 Psychiatry Update – a three-day meeting with renowned faculty and informative presentations on bipolar disorder, MDD,…
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
A melanoma survivor shares her journey, emphasizing the importance of sun safety and regular skin exams to prevent skin cancer.